2024 Q2 Form 10-Q Financial Statement

#000155837024006387 Filed on May 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $736.5M $632.0M
YoY Change 0.4% -13.13%
Cost Of Revenue $599.9M $514.0M
YoY Change -0.96% -15.08%
Gross Profit $136.5M $118.1M
YoY Change 6.86% -3.45%
Gross Profit Margin 18.54% 18.68%
Selling, General & Admin $105.2M $104.6M
YoY Change 7.51% 1.28%
% of Gross Profit 77.05% 88.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.273M $3.266M
YoY Change 5.79% 6.28%
% of Gross Profit 2.4% 2.77%
Operating Expenses $105.2M $104.6M
YoY Change 4.21% 1.28%
Operating Profit $30.92M $13.46M
YoY Change 15.3% -25.68%
Interest Expense $4.649M $4.567M
YoY Change 148.08%
% of Operating Profit 15.04% 33.92%
Other Income/Expense, Net
YoY Change
Pretax Income $35.57M $18.03M
YoY Change 32.0% -7.07%
Income Tax $9.407M $4.877M
% Of Pretax Income 26.45% 27.05%
Net Earnings $26.16M $13.15M
YoY Change 32.82% -7.35%
Net Earnings / Revenue 3.55% 2.08%
Basic Earnings Per Share $0.99 $0.50
Diluted Earnings Per Share $0.99 $0.50
COMMON SHARES
Basic Shares Outstanding 26.36M 26.36M
Diluted Shares Outstanding 26.52M 26.53M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $385.8M $352.0M
YoY Change 58.13% 161.07%
Cash & Equivalents $128.2M $147.6M
Short-Term Investments $257.6M $204.4M
Other Short-Term Assets $16.98M $16.93M
YoY Change 2.69% -6.72%
Inventory $136.6M $123.9M
Prepaid Expenses
Receivables $598.8M $527.3M
Other Receivables
Total Short-Term Assets $1.148B $1.023B
YoY Change 12.29% 5.05%
LONG-TERM ASSETS
Property, Plant & Equipment $54.38M $59.55M
YoY Change -14.75% 2.02%
Goodwill $73.60M $73.60M
YoY Change 0.0% 0.0%
Intangibles $2.819M $3.124M
YoY Change -30.19% -28.07%
Long-Term Investments
YoY Change
Other Assets $1.266M $1.434M
YoY Change 38.36% 41.56%
Total Long-Term Assets $136.0M $137.7M
YoY Change -4.47% -4.33%
TOTAL ASSETS
Total Short-Term Assets $1.148B $1.023B
Total Long-Term Assets $136.0M $137.7M
Total Assets $1.283B $1.161B
YoY Change 10.24% 3.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $317.1M $218.8M
YoY Change 14.38% -8.47%
Accrued Expenses $64.43M $71.01M
YoY Change -8.05% -0.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $388.6M $289.8M
YoY Change 11.9% -8.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.497M $2.779M
YoY Change -48.83% 313.54%
Total Long-Term Liabilities $2.497M $2.779M
YoY Change -48.83% 313.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $388.6M $289.8M
Total Long-Term Liabilities $2.497M $2.779M
Total Liabilities $408.6M $308.4M
YoY Change 10.37% -9.71%
SHAREHOLDERS EQUITY
Retained Earnings $794.9M $771.4M
YoY Change 11.07% 10.5%
Common Stock $135.3M $132.9M
YoY Change 4.22% 4.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $874.9M $852.7M
YoY Change
Total Liabilities & Shareholders Equity $1.283B $1.161B
YoY Change 10.24% 3.85%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $26.16M $13.15M
YoY Change 32.82% -7.35%
Depreciation, Depletion And Amortization $3.273M $3.266M
YoY Change 5.79% 6.28%
Cash From Operating Activities $38.39M $57.29M
YoY Change -66.89% 193.69%
INVESTING ACTIVITIES
Capital Expenditures $1.819M $1.608M
YoY Change -38.92% -14.56%
Acquisitions
YoY Change
Other Investing Activities -$50.00M -$50.00M
YoY Change
Cash From Investing Activities -$51.82M -$51.61M
YoY Change 1640.03% 2642.14%
FINANCING ACTIVITIES
Cash Dividend Paid $2.636M
YoY Change 25.11%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.939M -3.053M
YoY Change 56.74% -46.84%
NET CHANGE
Cash From Operating Activities 38.39M 57.29M
Cash From Investing Activities -51.82M -51.61M
Cash From Financing Activities -5.939M -3.053M
Net Change In Cash -19.37M 2.625M
YoY Change -117.74% -77.9%
FREE CASH FLOW
Cash From Operating Activities $38.39M $57.29M
Capital Expenditures $1.819M $1.608M
Free Cash Flow $36.57M $55.68M
YoY Change -67.62% 215.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
20440000
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
48400000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
19000
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities
CY2024Q1 us-gaap Debt Securities Fair Value By Fair Value Hierarchy Level Extensible List
DebtSecuritiesFairValueByFairValueHierarchyLevelExtensibleList
http://fasb.org/us-gaap/2023#FairValueInputsLevel1Member
CY2023Q4 us-gaap Debt Securities Fair Value By Fair Value Hierarchy Level Extensible List
DebtSecuritiesFairValueByFairValueHierarchyLevelExtensibleList
http://fasb.org/us-gaap/2023#FairValueInputsLevel1Member
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001050377
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
0-23827
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
PC CONNECTION, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
02-0513618
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
730 Milford Road
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Merrimack
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NH
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
03054
CY2024Q1 dei City Area Code
CityAreaCode
603
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
683-2000
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2024Q1 dei Trading Symbol
TradingSymbol
CNXN
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26363431
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
147579000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
144954000
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
204374000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
152232000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
527259000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
606834000
CY2024Q1 us-gaap Inventory Net
InventoryNet
123900000
CY2023Q4 us-gaap Inventory Net
InventoryNet
124179000
CY2024Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3318000
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4348000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16926000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16092000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
1023356000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1048639000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
55529000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
56658000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4020000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
43843000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
289808000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
327965000
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15806000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15844000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2760000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3181000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4340000
CY2024Q1 us-gaap Goodwill
Goodwill
73602000
CY2023Q4 us-gaap Goodwill
Goodwill
73602000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3124000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3428000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1434000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1714000
CY2024Q1 us-gaap Assets
Assets
1161065000
CY2023Q4 us-gaap Assets
Assets
1188381000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
218801000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
263682000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22607000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
624000
CY2024Q1 us-gaap Liabilities
Liabilities
308393000
CY2023Q4 us-gaap Liabilities
Liabilities
347614000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
293000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
293000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
132596000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
130878000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
771416000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
760898000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-62000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
81000
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
51571000
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
51383000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
852672000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
840767000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1161065000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1188381000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
632025000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
727545000
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
513953000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
605249000
CY2024Q1 us-gaap Gross Profit
GrossProfit
118072000
CY2023Q1 us-gaap Gross Profit
GrossProfit
122296000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
104608000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
103282000
CY2023Q1 cnxn Restructuring And Other Charges
RestructuringAndOtherCharges
897000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
13464000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
18117000
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4567000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1286000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18031000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19403000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4877000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5205000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
13154000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
14198000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26362000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26325000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26525000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26436000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
13154000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
14198000
CY2024Q1 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-38000
CY2024Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-143000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13011000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14198000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
840767000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1949000
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
231000
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
188000
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
134810000
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
336000
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2636000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
13154000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-143000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
852672000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
766175000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1853000
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
213000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3423000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.08
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2107000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
14198000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
776483000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
13154000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
14198000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3266000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3073000
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
269000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-99000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1949000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1853000
CY2024Q1 us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
2324000
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-21000
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-474000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-79306000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11465000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-279000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9365000
CY2024Q1 cnxn Increase Decrease In Prepaid Expense Income Tax Receivables And Other Current Assets
IncreaseDecreaseInPrepaidExpenseIncomeTaxReceivablesAndOtherCurrentAssets
-196000
CY2023Q1 cnxn Increase Decrease In Prepaid Expense Income Tax Receivables And Other Current Assets
IncreaseDecreaseInPrepaidExpenseIncomeTaxReceivablesAndOtherCurrentAssets
6245000
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-280000
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-42000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-45127000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5859000
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
6016000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2450000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
57285000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19505000
CY2024Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
99999000
CY2024Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
50000000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1608000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1882000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51607000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1882000
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
8349000
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
59310000
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
8349000
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
59310000
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
186000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3423000
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2636000
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2107000
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
231000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
213000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3053000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5743000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2625000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11880000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
144954000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122930000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
147579000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
753000
CY2024Q1 cnxn Accrued Excise Tax On Treasury Purchases
AccruedExciseTaxOnTreasuryPurchases
2000
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
635000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7279000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
1000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
17000
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Arial Unicode MS';font-size:9pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates in the Preparation of Financial Statements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts and disclosures of assets and liabilities and the reported amounts and disclosures of revenue and expenses during the period. Management bases its estimates and judgments on the information available at the time and various other assumptions believed to be reasonable under the circumstances. By nature, estimates are subject to an inherent degree of uncertainty. Actual results could differ from those estimates and assumptions.</p>
CY2024Q1 us-gaap Interest Income Short Term Investment Other
InterestIncomeShortTermInvestmentOther
4565000
CY2023Q1 us-gaap Interest Income Short Term Investment Other
InterestIncomeShortTermInvestmentOther
1308000
CY2024Q1 cnxn Repurchase Of Common Stock Including Excise Tax
RepurchaseOfCommonStockIncludingExciseTax
188000
CY2024Q1 cnxn Excise Tax Rate Stock Repurchase Percent
ExciseTaxRateStockRepurchasePercent
0.01
CY2023Q1 cnxn Repurchase Of Common Stock Including Excise Tax
RepurchaseOfCommonStockIncludingExciseTax
3423000
CY2024Q1 cnxn Restructuring And Other Charges
RestructuringAndOtherCharges
0
CY2023Q1 cnxn Restructuring And Other Charges
RestructuringAndOtherCharges
897000
CY2024Q1 cnxn Accrued Employee Termination Benefits
AccruedEmployeeTerminationBenefits
210000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
632025000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
727545000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4206000
CY2024Q1 cnxn Contract With Customer Liability Advance Payments Received
ContractWithCustomerLiabilityAdvancePaymentsReceived
5795000
CY2024Q1 cnxn Totalrevenuerecognizedfromboththebeginningbalanceandcurrentperiodincreaseincontractliability
Totalrevenuerecognizedfromboththebeginningbalanceandcurrentperiodincreaseincontractliability
1548000
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
8453000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4266000
CY2023Q1 cnxn Contract With Customer Liability Advance Payments Received
ContractWithCustomerLiabilityAdvancePaymentsReceived
7656000
CY2023Q1 cnxn Totalrevenuerecognizedfromboththebeginningbalanceandcurrentperiodincreaseincontractliability
Totalrevenuerecognizedfromboththebeginningbalanceandcurrentperiodincreaseincontractliability
4388000
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7534000
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
328448000
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
78000
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
328370000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
281252000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
103000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
281355000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
13154000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
14198000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26362000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26325000
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
163000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
111000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26525000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26436000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2024Q1 cnxn Number Of Additional Leases Not Yet Commenced
NumberOfAdditionalLeasesNotYetCommenced
0
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
459000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1022000
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
561000
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
128000
CY2024Q1 us-gaap Lease Cost
LeaseCost
1020000
CY2023Q1 us-gaap Lease Cost
LeaseCost
1150000
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
445000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
956000
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M1D
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y5M12D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0407
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0404
CY2024Q1 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2025-03-31
CY2024Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
80000000
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
8349000
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
59310000
CY2023Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
50000000
CY2024Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
50000000
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
0
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1534000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1813000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1120000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
237000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
161000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4865000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
256000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
4609000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4020000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2760000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1849000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4340000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3181000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1733000
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
632025000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
727545000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
13464000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
18117000
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4567000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1286000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18031000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19403000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3266000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3073000
CY2024Q1 us-gaap Assets
Assets
1161065000
CY2023Q1 us-gaap Assets
Assets
1118057000
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
0
CY2023Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
50000000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
81000
CY2024Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-135000
CY2024Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
8000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-143000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-62000
CY2024Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
50000000
CY2024Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
50000000
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-006387-index-headers.html Edgar Link pending
0001558370-24-006387-index.html Edgar Link pending
0001558370-24-006387.txt Edgar Link pending
0001558370-24-006387-xbrl.zip Edgar Link pending
cnxn-20240331.xsd Edgar Link pending
cnxn-20240331x10q.htm Edgar Link pending
cnxn-20240331xex10d1.htm Edgar Link pending
cnxn-20240331xex31d1.htm Edgar Link pending
cnxn-20240331xex31d2.htm Edgar Link pending
cnxn-20240331xex32d1.htm Edgar Link pending
cnxn-20240331xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
cnxn-20240331_cal.xml Edgar Link unprocessable
cnxn-20240331_def.xml Edgar Link unprocessable
cnxn-20240331_lab.xml Edgar Link unprocessable
cnxn-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cnxn-20240331x10q_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending